Barone Frank C, Gustafson Deborah, Crystal Howard A, Moreno Herman, Adamski Mateusz G, Arai Ken, Baird Alison E, Balucani Clotilde, Brickman Adam M, Cechetto David, Gorelick Philip, Biessels Geert Jan, Kiliaan Amanda, Launer Lenore, Schneider Julie, Sorond Farzaneh A, Whitmer Rachel, Wright Clinton, Zhang Zheng Gang
Neurology, SUNY Downstate Medical Center, Brooklyn, NY, USA.
Physiology and Pharmacology, SUNY Downstate Medical Center, Brooklyn, NY, USA.
J Transl Med. 2016 Feb 13;14:50. doi: 10.1186/s12967-016-0806-z.
As the human population continues to age, an increasing number of people will exhibit significant deficits in cognitive function and dementia. It is now recognized that cerebrovascular, metabolic and neurodegenerative diseases all play major roles in the evolution of cognitive impairment and dementia. Thus with our more recent recognition of these relationships and our need to understand and more positively impact on this world health problem, "The Leo and Anne Albert Charitable Trust" (Gene Pranzo, Trustee with significant support from Susan Brogan, Meeting Planner) provided generous support for this inaugural international workshop that was held from April 13-16, 2015 at the beautiful Ritz Carlton Golf Resort in North Naples, Florida. Researchers from SUNY Downstate Medical Center, Brooklyn, NY organized the event by selecting the present group of translationally inclined preclinical, clinical and population scientists focused on cerebrovascular disease (CVD) risk and its progression to vascular cognitive impairment (VCI) and dementia. Participants at the workshop addressed important issues related to aging, cognition and dementia by: (1) sharing new data, information and perspectives that intersect vascular, metabolic and neurodegenerative diseases, (2) discussing gaps in translating population risk, clinical and preclinical information to the progression of cognitive loss, and (3) debating new approaches and methods to fill these gaps that can translate into future therapeutic interventions. Participants agreed on topics for group discussion prior to the meeting and focused on specific translational goals that included promoting better understanding of dementia mechanisms, the identification of potential therapeutic targets for intervention, and discussed/debated the potential utility of diagnostic/prognostic markers. Below summarizes the new data-presentations, concepts, novel directions and specific discussion topics addressed by this international translational team at our "First Leo and Anne Albert Charitable Trust 'Think Tank' VCI workshop".
随着人口持续老龄化,越来越多的人将出现认知功能严重缺陷和痴呆症。现在人们认识到,脑血管疾病、代谢性疾病和神经退行性疾病在认知障碍和痴呆症的发展过程中都起着主要作用。因此,鉴于我们最近对这些关系的认识,以及我们需要理解并更积极地应对这一全球健康问题,“利奥和安妮·阿尔伯特慈善信托基金”(受托人吉恩·普兰佐,在会议策划人苏珊·布罗根的大力支持下)为2015年4月13日至16日在佛罗里达州那不勒斯北部美丽的丽思卡尔顿高尔夫度假村举行的首届国际研讨会提供了慷慨支持。纽约州立大学唐斯泰特医学中心的研究人员组织了此次活动,他们挑选了目前这批倾向于转化医学的临床前、临床和群体科学家,这些科学家专注于脑血管疾病(CVD)风险及其向血管性认知障碍(VCI)和痴呆症的发展。研讨会上的参与者通过以下方式探讨了与衰老、认知和痴呆症相关的重要问题:(1)分享与血管、代谢和神经退行性疾病相关的新数据、信息和观点;(2)讨论在将群体风险、临床和临床前信息转化为认知丧失进展方面存在的差距;(3)辩论填补这些差距的新方法和新途径,这些方法可转化为未来的治疗干预措施。参与者在会议前就小组讨论的主题达成了一致,并专注于具体的转化目标,包括促进对痴呆症机制的更好理解、确定潜在的干预治疗靶点,并讨论/辩论诊断/预后标志物的潜在效用。以下总结了这个国际转化医学团队在我们的“首届利奥和安妮·阿尔伯特慈善信托基金‘智囊团’VCI研讨会”上展示的新数据、概念、新方向和具体讨论主题。